HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.

Abstract
A family of different 3,5-disubstituted indole derivatives having 6-membered rings were designed, synthesized, and demonstrated inhibition of human nitric oxide synthase (NOS) with norepinephrine reuptake inhibitory activity (NERI). The structure-activity relationship (SAR) within the cyclohexane ring showed the cis-isomers to be more potent for neuronal NOS and selective over endothelial NOS compared to their trans-counterparts. Compounds, such as cis-(+)-37, exhibited dual nNOS and NET inhibition (IC(50) of 0.56 and 1.0 μM, respectively) and excellent selectivity (88-fold and 12-fold) over eNOS and iNOS, respectively. The lead compound (cis-(+)-37) showed lack of any direct vasoconstriction or inhibition of ACh-mediated vasorelaxation in isolated human coronary arteries. Additionally, cis-(+)-37 was effective at reversing both allodynia and thermal hyperalgesia in a standard Chung (spinal nerve ligation) rat neuropathic pain model. Overall, the data suggest that cis-(+)-37 is a promising dual action development candidate having therapeutic potential for the treatment of neuropathic pain.
AuthorsGabriela Mladenova, Subhash C Annedi, Jailall Ramnauth, Shawn P Maddaford, Suman Rakhit, John S Andrews, Dongqin Zhang, Frank Porreca
JournalJournal of medicinal chemistry (J Med Chem) Vol. 55 Issue 7 Pg. 3488-501 (Apr 12 2012) ISSN: 1520-4804 [Electronic] United States
PMID22420844 (Publication Type: Journal Article)
Copyright© 2012 American Chemical Society
Chemical References
  • Adrenergic Uptake Inhibitors
  • Analgesics
  • Cyclohexanes
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • Indoles
  • N-(3-(3-(methylamino)cyclohexyl)-1H-indol-5-yl)thiophene-2-carboximidamide
  • Norepinephrine Plasma Membrane Transport Proteins
  • Thiophenes
  • Nitric Oxide Synthase Type I
Topics
  • Adrenergic Uptake Inhibitors (chemical synthesis, chemistry, pharmacology)
  • Analgesics (chemical synthesis, chemistry, pharmacology)
  • Animals
  • CHO Cells
  • Coronary Vessels (drug effects, physiology)
  • Cricetinae
  • Cricetulus
  • Cyclohexanes (chemical synthesis, chemistry, pharmacology)
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels (antagonists & inhibitors)
  • HEK293 Cells
  • High-Throughput Screening Assays
  • Humans
  • In Vitro Techniques
  • Indoles (chemical synthesis, chemistry, pharmacology)
  • Muscle Contraction
  • Muscle, Smooth, Vascular (drug effects, physiology)
  • Neuralgia (drug therapy)
  • Nitric Oxide Synthase Type I (antagonists & inhibitors)
  • Norepinephrine Plasma Membrane Transport Proteins (metabolism)
  • Rats
  • Stereoisomerism
  • Structure-Activity Relationship
  • Thiophenes (chemical synthesis, chemistry, pharmacology)
  • Vascular Resistance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: